Twist Bioscience is scaling a silicon-powered synthetic biology platform into a high-growth bio-industrial utility, with strong AI and genomics tailwinds offset by profitability, dilution, and competitive pricing risks.
Overview
Twist Bioscience is a synthetic biology infrastructure leader built around a proprietary silicon DNA synthesis platform that uses 9,600 nanowells to reduce reagent usage by roughly 10,000x versus legacy methods. Revenue spans DNA synthesis and protein solutions, NGS target enrichment, and biopharma partnerships, serving pharma, biotech, diagnostics, academic, government, and agriculture customers globally. Customers choose Twist for high-throughput, high-fidelity DNA, rapid five-day Express Genes turnaround, workflow integration, and cost efficiency. The company is increasingly positioned as a key utility provider for AI-driven drug discovery, clinical genomics, and custom bio-data workflows.